ABOUT TRIALSCOPE

TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that are designed to optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit trialscope.com.

FEATURED PRODUCTS

Designed as a free, credible resource for both the public and research professionals, CoronaClinicalTrials.com automatically syncs study information from ClinicalTrials.gov. The website also features educational material provided by the Center for Information and Study on Clinical Research Participation (CISCRP).

In order to demonstrate a deeper commitment to clinical trial transparency than the law requires, some sponsors are choosing to provide additional information about their portfolio of clinical trials on a dedicated website. TrialScope Engage can help sponsors manage clinical trial content that is being prepared for disclosure on their own sites.

PharmaCM is a clinical trial disclosure platform designed specifically for the regulated environment of Life Sciences. PharmaCM is used to manage the complex process of authoring, reviewing, editing, approving and publishing clinical trial application and disclosure data. Disclosure content is very dynamic. Clinical trial data is constantly being updated, modified and formatted for specific registries such as ClinicalTrials.gov and EudraCT.

CLINICAL TRANSPARENCY
Clinical trial sponsors are required by law to disclose information on their clinical trials in multiple places. These regulatory requirements continue to change as new mandated registries emerge and the scope of disclosure expands. This dynamic scenario creates a challenge for sponsors who must track and manage disclosure content that is being prepared for different registries, with different requirements.

CONTACT INFORMATION

TrialScope

185 Hudson St #2900

Jersey City, NJ 07311

UNITED STATES

Phone: 877-658-8310

Contact: Naor Chazan

FEATURED CONTENT

  • Sponsor Transparency Commitments

    Representatives from Teva and Lung Biotechnology talk with TrialScope about the difference in clinical trial transparency commitments of larger pharmaceutical companies and smaller biotechs. Watch this short video.

  • Disclosure As A Service ROI

    How do sponsors determine the ROI of Disclosure as a Service? TrialScope talks with two sponsors – a large pharmaceutical company and a smaller biotech – for their take on this. Watch the short video.

  • Getting Buy-In For Disclosure As A Service

    Clinical trial disclosure teams often have a tough time convincing upper management on the benefits of Disclosure as a Service. Hear how two sponsors “sold” the idea of outsourcing this function. Watch the short TrialScope interview.

  • Benefits Of Clinical Trial Transparency

    TrialScope asks two study sponsors to sound off on how clinical trial transparency benefits their organizations and the industry as a whole. Watch the short video.

  • Transparency & Patient Centricity

    Clinical trial transparency fosters both patient centricity and patient engagement. TrialScope asks two study sponsors to shed light on this topic. Watch the short video.

  • Evolution Of Transparency Policies

    In recent years, many sponsors have established or expanded their clinical trial transparency commitments. TrialScope speaks with two sponsors to find out how their organizations’ transparency commitment and policies have evolved. Watch the short video.

  • Outsourcing Clinical Trial Disclosure Management

    Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.

  • Why Disclosure As A Service?

    Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.

  • Sponsors' Advice On Disclosure As A Service

    Representatives from Teva and Lung Biotechnology share their insights for other sponsors considering Disclosure as a Service. Watch the short video now.

  • A Blueprint for Building a Successful Plain Language Summaries Program

    There’s more involved in creating plain language summaries than meets the eye. This planning guide addresses all aspects of PLS, from regulatory requirements to team roles and timelines.

  • TrialScope’s Mike Wenger Named A 2020 PM360 ELITE 100 Patient Advocate

    Mike Wenger, Vice President of Patient Engagement at TrialScope, has been named one of the 2020 PM360 ELITE 100 in the Patient Advocates category. The PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represents the most influential people in the healthcare industry today.

  • How Sponsors Turn Disclosure As A Service Into A Strategic Advantage

    In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.

  • TrialScope Video A WEGO Health Patient-Choice Awards Winner

    TrialScope’s “Real Patient Stories: The Trials of Finding Clinical Trials” video has won a Silver award in the WEGO Health Patient-Choice Awards for Most Authentic Use of Patients in a Marketing Campaign.

  • Clinical Trial Disclosures On The World Map

    TrialScope Chief Strategy Officer Thomas Wicks discusses the changing nature of clinical trials: how they are conducted, reported and regulated, along with compliance issues. Listen now.

  • Roadblocks At The On-Ramp To The Clinical Trial Participant's Journey – And How Better Data Can Remove Them

    Mike Wenger, TrialScope Vice President of Patient Engagement, addresses patient challenges in accessing clinical trials. Craig Lipset, former head of innovation at Pfizer, explores new ways of approaching the industry's study recruitment dilemma.

  • Transparency & Other Takeaways From COVID-19 Clinical Trials

    The coronavirus pandemic, with #COVID-19 clinical trials underway, underscores the importance for clinical data sharing, clinical trial transparency, and plain language summaries.

  • New Website A Free Resource for Researchers, Patients On COVID-19 Trials

    CoronaClinicalTrials.com curates study information from government sources to provide a source of credible information on coronavirus clinical studies. The website automatically syncs clinical trial information from ClinicalTrials.gov and includes educational resources from CISCRP.

  • Want To Be More Patient Centric? Start With Plain Language Summaries

    What do plain language summaries have to do with patient centricity? Everything! Our infographic highlights regulations, PLS impact on enrollment & more. And be sure to visit the Trial Summaries site with PLS of various sponsors.

  • An Often-Overlooked Way To Participate In Clinical Research

    Many blood donors don't realize that their blood also can be used in clinical research. Now, as COVID-19 threatens to create blood shortages, donating blood is more important than ever.

  • PLS Perspectives: Sponsor, Author & Regulatory Viewpoints

    In this informative webinar, Jazz Pharmaceuticals will provide tips on launching a PLS program. A medical writer from ClaritiDox will give an overview of PLS best practices. And TrialScope’s chief strategy officer will share – and analyze – results from TrialScope’s recent PLS survey.